Opinion

Video

Personalizing ADC Therapy in mBC Based on Patient Characteristics and Prior Therapies

Author(s):

Heather Moore, BCOP, CPP, PharmD, Jodi Taraba, PharmD, MS, BCOP

Panelists discuss how patient characteristics significantly impact antibody-drug conjugate (ADC) therapy selection, with key factors including the presence and location of brain metastases (due to blood-brain barrier penetration), organ function and comorbidities affecting toxicity risks, and prior treatment history that may influence both efficacy and safety. Treatment decisions require careful individualization.

Video content above has been prompted by the following:

  • How do patient characteristics (eg, brain metastases, other comorbidities, prior therapies) influence ADC therapy selection?
Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
4 experts are featured in this series.
4 experts are featured in this series.
5 experts in this video
Related Content
Patient Case Study: Use of Dietary Supplements in Patients With Breast Cancer
March 10th 2025

Patient Case Study: Use of Dietary Supplements in Patients With Breast Cancer

Sheikh Zakaria, PharmD Michele Riccardi, PharmD, BCPS
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
3D illustration of TNBC cell | Image Credit: © LASZLO - stock.adobe.com
February 27th 2025

Navigating Triple-Negative Breast Cancer Treatment With Sacituzumab Govitecan

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Black woman holding pink ribbon for breast cancer awareness -- Image credit: Maria Vitkovska | stock.adobe.com
February 13th 2025

Equitable Representation in Triple-Negative Breast Cancer Clinical Trials

Britny Brown, PharmD, BCOP Madison Savidge, PharmD, MBA Olivia Arukwe, PharmD
Genetic Diversity in African Populations Can Advance Precision Medicine Globally
February 8th 2025

Genetic Diversity in African Populations Can Advance Precision Medicine Globally

Alana Hippensteele, Lead Editor